vatalanib has been researched along with Inflammation in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koskinen, PK; Krebs, R; Lemström, KB; Nykänen, AI; Raisky, O; Sihvola, R; Tikkanen, JM; Wood, J | 1 |
1 other study(ies) available for vatalanib and Inflammation
| Article | Year |
|---|---|
Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation.
Topics: Angiogenesis Inhibitors; Animals; Arteriosclerosis; Benzamides; Graft Rejection; Heart Transplantation; Imatinib Mesylate; Inflammation; Male; Muscle, Smooth, Vascular; Phthalazines; Piperazines; Platelet-Derived Growth Factor; Postoperative Complications; Pyridines; Pyrimidines; Rats; Rats, Inbred Strains; Rats, Inbred WF; Receptors, Platelet-Derived Growth Factor; RNA, Messenger; Transplantation, Homologous; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2005 |